๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cost-effectiveness of hepatitis B vaccine in The Gambia

โœ Scribed by Andrew J. Hall; Robert L. Roberston; Paolo E. Crivelli; Yamandow Lowe; Hazel Inskip; Sharon K. Snow; Hilton Whittle


Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
524 KB
Volume
87
Category
Article
ISSN
0035-9203

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Cost-effectiveness analysis of the Lyme
โœ Elizabeth C. Hsia; James B. Chung; J. Sanford Schwartz; Daniel A. Albert ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 131 KB ๐Ÿ‘ 2 views
Cost-effectiveness analysis of vaccinati
โœ E. van Doorslaer; G. Tormans; P. van Damme ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 605 KB

## Abstract Hepatitis A virus (HAV) infection is a substantial risk for travellers from low endemic countries to high endemic destinations. Costs and effects of alternative options for prevention were compared using formal decision analysis. General indications for the optimal prevention of hepatit

Cost-effectiveness of nationwide hepatit
โœ David W. Hutton; Samuel K. So; Margaret L. Brandeau ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 308 KB

Liver disease and liver cancer associated with childhood-acquired chronic hepatitis B are leading causes of death among adults in China. Despite expanded newborn hepatitis B vaccination programs, approximately 20% of children under age 5 years and 40% of children aged 5 to 19 years remain unprotecte

Cost-effectiveness analysis of hepatitis
โœ J. Barry O'Connor; Thomas F. Imperiale; Mendel E. Singer ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 1 views

Our objective in this study was to determine the costeffectiveness of hepatitis A vaccination strategies in healthy adults in the United States. We constructed a decision model simulating costs and health consequences for otherwise healthy adults with respect to hepatitis A prevention. Three strateg

Cost-effectiveness of interferon alfa 2b
โœ W. Ray Kim; John J. Poterucha ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 34 KB ๐Ÿ‘ 2 views

In their paper in the November issue of HEPATOLOGY, Younossi et al. 1 may have overestimated the cost effectiveness of interferon-ribavirin treatment. This mainly stems from their failure to take into account the fact that patients who achieve sustained response are not homogenous with respect to th